Source: International Congress 2016 – Sarcoidosis



Rating:

Share or cite this content

Citations should be made in the following way:
Michał Bednarek (Warszawa, Poland), Michal Bednarek, Anna Goljan-Geremek, Elzbieta Puscinska, Adam Nowinski, Damian Korzybski, Pawel Sliwinski. Incidence and prognostic factors for airflow obstruction in sarcoidosis. Eur Respir J 2016; 48: Suppl. 60, 824

Member's Comments

No comment yet.

Related content which might interest you: Airway obstruction in sarcoidosis Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases Year: 2008 Clinically remitted childhood asthma is a risk factor for airflow obstruction in middle-aged adults Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015 Small airways disease and peripheral eosinophilia predict airway hyperresponsiveness in Irish patients with suspected asthma Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage? Year: 2015 Consequences of different definitions of airway obstruction Source: International Congress 2015 – Epidemiology of respiratory disease Year: 2015 Severity of airway obstruction in overweight/obese patients with chronic obstructive pulmonary disease(COPD) Source: International Congress 2014 – Monitoring airway diseases with lung function tests Year: 2014 Reversibility of airway obstruction in sarcoidosis patients Source: Eur Respir J 2003; 22: Suppl. 45, 276s Year: 2003 Patterns of spirometry in bronchiectasis patients and relationship to markers of disease severity and hospitalisation Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013 Characteristics of patients with persistent airflow obstruction from an asthma clinic Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes Year: 2013 What defines airflow obstruction in asthma? Source: Eur Respir J 2009; 34: 568 Year: 2009 Sarcoidosis and airway obstruction Source: Annual Congress 2009 - Pleural and parenchymal diseases Year: 2009 Long-term outcome in non-reversible and reversible airway obstruction Source: International Congress 2015 – COPD and lung function: risk factors and outcomes Year: 2015 High prevalence of undiagnosed airflow obstruction in patients with ischaemic heart disease Source: International Congress 2014 – Direct and indirect monitoring of comorbidities Year: 2014 The usefulness of FeNO and the mannitol test in detecting airway eosinophilia in asthma patients with uncontrolled symptoms Source: International Congress 2014 – Biomarkers of asthma control Year: 2014 The effects of bronchodilators in patients with tuberculosis-destroyed lung and chronic airflow obstruction Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015 Non-invasive evaluation of airway inflammation in non-CF bronchiectasis Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections Year: 2016 Precision of bronchoprovocation testing in the diagnosis of exercise-induced laryngeal obstruction Source: International Congress 2015 – Co-existing diseases and asthma Year: 2015 Pulmonary function and sinonasal symptoms in asthmatics Source: Eur Respir J 2006; 28: Suppl. 50, 845s Year: 2006 Pseudo hyperinflation of lung in patients with achalasia Source: International Congress 2016 – The best clinical approach to lung diseases Year: 2016 Air trapping in relation to airways inflammation and bronchial responsiveness in patients with respiratory symptoms suggestive of asthma Source: International Congress 2014 – Monitoring airway diseases with lung function tests Year: 2014 The outcome of broncho-dilation among subjects with airway obstruction in the general population Source: International Congress 2014 – Lung function, COPD and inflammation Year: 2014